The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 28, 2021
Filed:
Nov. 07, 2017
Applicant:
The University of Louisiana AT Lafayette, Lafayette, LA (US);
Inventors:
Ruth M. Ruprecht, Lafayette, LA (US);
Hemant K. Vyas, San Antonio, TX (US);
Assignee:
Other;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 16/00 (2006.01); A61K 39/00 (2006.01); C07K 14/005 (2006.01); C07K 16/10 (2006.01); A61K 39/21 (2006.01); C12N 7/00 (2006.01); A61P 31/18 (2006.01); A61K 39/12 (2006.01); A61P 31/14 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 39/12 (2013.01); A61P 31/14 (2018.01); A61P 31/18 (2018.01); C07K 14/005 (2013.01); C07K 16/1063 (2013.01); C12N 7/00 (2013.01); A61K 2039/55566 (2013.01); C12N 2740/15034 (2013.01); C12N 2740/16071 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16134 (2013.01); C12N 2740/16171 (2013.01); C12N 2740/16334 (2013.01);
Abstract
Provided herein are recombinant nucleic acid sequences derived from the C-terminal domain of the HIV-1 gp41 protein, and more specifically compositions and methods for using these epitopes to develop vaccine protection against HIV. Also provided here are monoclonal antibodies that specifically bind to these recombinant nucleic acid sequences derived from the C-terminal domain of the HIV-1 gp41 protein.